![Lee Su-Leng Tan](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Su Leng Tan Lee is President, CEO, Secretary & Director at BioNexus Gene Lab Corp.
since 2025.
Formerly, Mr. Tan Lee was Managing Director at Flo Life Sciences from 2017 to 2023, President at Avillion Bhd.
from 2018 to 2019,.
and Chief Commercial Officer at Dryox Health SL from 2022 to 2023.
| Sociétés | Poste | Début |
|---|---|---|
| BIONEXUS GENE LAB CORP. | Directeur Général | 11/12/2023 |
| Sociétés | Poste | Fin |
|---|---|---|
Dryox Health SL
 Dryox Health SL BiotechnologyHealth Technology Develops dermatological therapies | Corporate Officer/Principal | 01/08/2023 |
| AVILLION | President | 01/04/2019 |
Actives
Inactives
Sociétés cotées
Entreprise privées
| Entreprise privées | 3 |
|---|---|
Avillion Bhd.
 Avillion Bhd. Other Consumer ServicesConsumer Services Operates as an investment holding company which engages in the business of travel and tour operations, hire of coach and other related services | Consumer Services |
BioNexus Gene Lab Corp.
 BioNexus Gene Lab Corp. Wholesale DistributorsDistribution Services Distributes chemical raw materials | Distribution Services |
Dryox Health SL
Dryox Health SL BiotechnologyHealth Technology Develops dermatological therapies | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national
